Composite hemostatic dressing as well as preparation method and application thereof

Through the Janus structure of composite hemostatic dressing, the bonding of cellulose paper and polyacrylamide hydrogel layer is solved, and the problem of insufficient blood absorption performance of existing hemostatic materials is achieved, rapid hemostatic and good biocompatibility are reduced. Environmental pollution and promote wound healing.

CN118987318APending Publication Date: 2024-11-22WENZHOU MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411104647.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing hemostatic materials have shortcomings in absorbing blood, elasticity and biocompatibility, making them difficult to effectively control trauma and surgical bleeding, and are susceptible to contamination and lack of degradability.

Method used

Compound hemostatic dressing, including cellulose paper layer and polyacrylamide hydrogel layer, forms a Janus structure, and forms a relatively hydrophobic-hydrophilic structure after bonding, quickly absorbs blood and ooze, and has excellent hemostatic properties and biological Compatibility, elasticity and degradability.

Benefits of technology

It achieves rapid absorption of blood and ooze, effectively controls bleeding, reduces patient mortality, has good biocompatibility and degradability, reduces environmental pollution, and promotes wound healing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118987318A_ABST
    Figure CN118987318A_ABST
Patent Text Reader

Abstract

The invention discloses a composite hemostatic dressing as well as a preparation method and application thereof, and relates to the technical field of hemostatic materials. The cellulose paper layer and the polyacrylamide hydrogel layer are attached, the cellulose paper layer has high porosity, good mechanical performance and hemostatic performance, the polyacrylamide hydrogel layer has high porosity, excellent mechanical performance, elasticity and biocompatibility, and a relatively hydrophobic-hydrophilic structure is formed after the cellulose paper layer and the polyacrylamide hydrogel layer are attached. The hemostatic material can quickly absorb blood and permeate, and has excellent hemostatic performance, biocompatibility, elasticity and degradability.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of hemostatic materials, and in particular to a composite hemostatic dressing, and a preparation method and application thereof. Background Art

[0002] Trauma and surgical bleeding can increase the patient's pain and mortality. Hemostatic dressings such as gauze and hemostatic powder can reduce bleeding to a certain extent, but they still have certain limitations, such as absorbing excessive blood, being easily contaminated, and lacking elasticity.

[0003] Therefore, there is an urgent need to develop hemostatic materials with excellent hemostatic properties, good biocompatibility, good elasticity and good degradability.

[0004] In view of this, the present invention is proposed. Summary of the invention

[0005] The purpose of the present invention is to provide a composite hemostatic dressing, a preparation method and application thereof, aiming at preparing a hemostatic material with excellent hemostatic performance, good biocompatibility, good elasticity and good degradability.

[0006] The present invention is achieved in that:

[0007] In a first aspect, the present invention provides a composite hemostatic dressing, comprising a cellulose paper layer and a polyacrylamide hydrogel layer bonded to the cellulose paper layer.

[0008] In an optional embodiment, the cellulose paper layer and the polyacrylamide hydrogel layer form a Janus structure;

[0009] and / or, the contact angle between the cellulose paper layer and the polyacrylamide hydrogel layer is greater than 90°;

[0010] And / or, the thickness of the cellulose paper layer is 100 μm-150 μm, and the thickness of the polyacrylamide hydrogel layer is 1 μm-2 μm.

[0011] In an optional embodiment, the pore size of the polyacrylamide hydrogel layer is 10 μm-100 μm;

[0012] And / or, the tensile strength of the polyacrylamide hydrogel layer is greater than 1 MPa, and the elongation at break is greater than 100%.

[0013] In an alternative embodiment, the fiber length in the cellulose paper layer is 10 μm to 100 μm, and the fiber diameter is 1 μm to 10 μm.

[0014] In a second aspect, the present invention provides a method for preparing any one of the composite hemostatic dressings described above, comprising: laminating cellulose paper and polyacrylamide hydrogel.

[0015] In an optional embodiment, the polyacrylamide hydrogel is placed on a flat surface, and the cellulose paper is attached to the polyacrylamide hydrogel;

[0016] The laminating temperature is controlled at 20℃-40℃ and the laminating time is 10min-30min.

[0017] In an alternative embodiment, the cellulose paper is prepared from plant residues;

[0018] The plant residue is selected from at least one of paper mulberry bark, lemongrass and marigold.

[0019] In an optional embodiment, the preparation process of cellulose paper includes: removing impurities from plant residues, washing and crushing them to obtain fiber raw materials;

[0020] Dispersing fiber raw materials in water to form a fiber suspension, and using the fiber suspension to make cellulose paper;

[0021] Drying the cellulose paper;

[0022] Preferably, the process of removing impurities comprises: soaking the plant residues in lime water.

[0023] In an optional embodiment, the preparation process of the polyacrylamide hydrogel includes: irradiating the polyacrylamide with ultraviolet light in the presence of a crosslinking agent and a photoinitiator, obtaining a hydrogel layer after crosslinking and curing, and performing swelling treatment on the hydrogel layer;

[0024] Preferably, the process of preparing the hydrogel layer includes: mixing and dissolving polyacrylamide and water to obtain a polyacrylamide solution, mixing the polyacrylamide solution with a crosslinker and a photoinitiator to obtain a reaction solution, pouring the reaction solution into a mold, and crosslinking and curing by ultraviolet light to obtain a hydrogel layer.

[0025] In a third aspect, the present invention provides use of any of the composite hemostatic dressings described in the foregoing embodiments or a composite hemostatic dressing prepared by any of the preparation methods described in the foregoing embodiments in the preparation of hemostatic drugs.

[0026] The present invention has the following beneficial effects: the present invention utilizes a cellulose paper layer and a polyacrylamide hydrogel layer to bond together; the cellulose paper layer has high porosity, good mechanical properties and hemostatic properties; the polyacrylamide hydrogel layer has high porosity, excellent mechanical properties, elasticity and biocompatibility; after bonding together, the two form a relatively hydrophobic-hydrophilic structure, which can quickly absorb blood and penetrate, and has excellent hemostatic properties, biocompatibility, elasticity and degradability. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.

[0028] Figure 1 Schematic diagram of the preparation of Janus dressing;

[0029] Figure 2 This is a physical picture of the surface and cross section of the Janus dressing;

[0030] Figure 3 The blood absorption performance test diagram of Janus dressing; A represents the blood absorption performance appearance diagram of SBMA hydrogels of three thicknesses, Bandage, BP, CT, and CL, and Janus dressing, scale bar = 1 cm; B represents the blood absorption rate of SBMA hydrogels of three thicknesses, Bandage, BP, CT, and CL, and Janus dressing, n = 3; C represents the blood absorption rate of SBMA hydrogels of three thicknesses, Bandage, BP, CT, and CL, and Janus dressing per second, n = 3;

[0031] Figure 4 The figure is a test diagram of the exudate absorption performance of Janus dressing; A represents the apparent figure of the exudate absorption performance of SBMA hydrogels of three thicknesses, Bandage, BP, CT, and CL, and Janus dressing, scale bar = 1 cm; B represents the exudate absorption rate of SBMA hydrogels of three thicknesses, Bandage, BP, CT, and CL, and Janus dressing, n = 3; C represents the exudate absorption rate of SBMA hydrogels of three thicknesses, Bandage, BP, CT, and CL, and Janus dressing per second, n = 3;

[0032] Figure 5 The water vapor permeability test pictures of Janus dressings; A represents the water vapor permeability test surface diagram of Bandage, BP, CT, CL, three thicknesses of SBMA hydrogel and Janus dressing for 24 hours, scale bar = 1 cm; B represents the water vapor permeability of Bandage, BP, CT, CL, three thicknesses of SBMA hydrogel and Janus dressing for 24 hours, n = 3;

[0033] Figure 6 A radar chart comparing the relevant properties of SBMA hydrogels with three thicknesses;

[0034] Figure 7The figure shows the rapid blood absorption performance of Janus structure; A shows the blood droplet on the surface of BP, CT, CL, BPHB, CTHB and CLHB from dripping to penetration absorption; B shows the blood initial contact angle measurement picture of BP, CT, CL and HB; C shows the schematic diagram of rapid blood penetration absorption; D shows the blood initial contact angle measurement statistical graph of BP, CT, CL and HB, n=3; E shows the time required for the blood droplet on the surface of BP, CT, CL, BPHB, CTHB and CLHB from dripping to penetration absorption, n=3. *** indicates P<0.001; F shows the relative blood permeability of BP vs BPHB, CT vs CTHB and CL vs CLHB;

[0035] Figure 8 Figure 1 is a graph of the rapid absorption performance of Janus structure; A is a graph of the rapid absorption of liquid from dripping to penetration on the surface of BP, CT, CL, BPHB, CTHB and CLHB; B is a graph of the initial contact angle measurement of liquid on BP, CT, CL and HB; C is a schematic diagram of the rapid absorption of liquid; D is a statistical graph of the initial contact angle measurement of liquid on BP, CT, CL and HB, n = 3; E is the time required for the droplet on the surface of BP, CT, CL, BPHB, CTHB and CLHB to be absorbed from dripping, n = 3; *** indicates P < 0.001; F is the relative permeability of liquid on BP vs BPHB, CT vs CTHB and CL vs CLHB;

[0036] Fig. 9 The diagram is a diagram of the mechanism of rapid liquid absorption by the Janus structure; A is a schematic diagram of the Young's equation on the surface of the cellulose paper and B is a schematic diagram of the Young's equation on the surface of the hydrogel layer; C is a force analysis of the droplet from the cellulose paper layer to the hydrogel layer based on the Laplace equation;

[0037] Fig.10 Figure 1 is a diagram of the skin irritation test of Janus dressing; A is a picture of the appearance of rat skin 72 hours after being treated 3 times with BP, CT, CL, HB, BPHB, CTHB, CLHB, Saline (negative control) and 20% SDS (positive control), scale bar = 0.5 cm; B is a H&E picture of rat skin 72 hours after being treated 3 times with BP, CT, CL, HB, BPHB, CTHB, CLHB, Saline (negative control) and 20% SDS (positive control), scale bar = 100 μm;

[0038] Fig.11Figure 1 is a blood compatibility test diagram of Janus dressing; A represents the surface diagram (scale bar = 1 cm) and optical micrograph (scale bar = 50 μm) of the hemolysis test of Saline (negative control), Water (positive control) and 24h extracts of BP, CT, CL, HB, BPHB, CTHB, CLHB of different areas and red blood cell 24h extracts; B represents the hemolysis rate of Saline (negative control), Water (positive control) and 24h extracts of BP, CT, CL, HB, BPHB, CTHB, CLHB of different areas;

[0039] Fig.12 Figure 2 shows the cell compatibility test of Janus dressings; A shows the cell live / dead test of Janus dressings. The extracts of BP, CT, CL, HB, BPHB, CTHB and CLHB were treated with NIH 3T3 cells for 24 hours, and then the live cells (green) and dead cells (red) were imaged under a fluorescence microscope; Scale bar = 200 μm; B shows the cell viability test of Janus dressings; Cytotoxicity evaluation of BP, CT, CL, HB, BPHB, CTHB and CLHB extracts on mouse embryonic fibroblasts (NIH3T3), n = 5;

[0040] Fig.13 Figure 2 shows the adhesion of red blood cells and platelets on Janus dressings; A shows the mechanism of rapid hemostasis of Janus dressings; B shows the SEM images of red blood cells and platelets attached to Bandage, BP, CT, CL, BPHB, CTHB and CLHB (blue arrows: fibrin; red arrows: platelets); scale bar = 10 μm;

[0041] Fig.14 This is the anti-adhesion test diagram of Janus dressing in mice;

[0042] Fig.15 Janus dressings are applied to rats for tooth extraction bleeding; A is a schematic diagram of rat tooth extraction bleeding; B is the appearance of Control, Bandage, BPHB, CTHB and CLHB applied to rats for tooth extraction bleeding after 30s and 60s; C is the appearance of the wound site after Control, Bandage, BPHB, CTHB and CLHB were applied to rats for tooth extraction bleeding for 60s, and the residual blood was wiped with cotton balls after the materials were removed, scale = 0.5cm; D is a picture of residual bleeding wiped with cotton balls, scale = 1cm; E is a statistical chart of hemostasis time of each group after rat tooth extraction bleeding, n = 3; F is a statistical chart of blood loss of each group after rat tooth extraction bleeding, n = 3;

[0043] Fig.16Figure 1 shows Janus dressing applied to rat tail bleeding; A shows a schematic diagram of rat tail bleeding; B shows the appearance of Control, Bandage, BPHB, CTHB and CLHB applied to rat tail bleeding 30s and 60s after cutting, scale bar = 1cm; C shows the statistical diagram of hemostasis time of each group after rat tail bleeding, n = 3; D shows the statistical diagram of blood loss of each group after rat tail bleeding, n = 3;

[0044] Fig.17 Figure 1 shows the bleeding of rat liver after Janus dressing was applied; A shows the schematic diagram of rat liver bleeding; B shows the appearance of Control, Bandage, BPHB, CTHB and CLHB after 30s and 60s of bleeding in rat liver, scale bar = 1cm; C shows the H&E staining image of the liver after 1min of bleeding in rat liver after Control, Bandage, BPHB, CTHB and CLHB were applied, scale bar = 100μm; D shows the statistical diagram of hemostasis time of each group after bleeding in rat liver, n = 3; E shows the statistical diagram of blood loss of each group after bleeding in rat liver, n = 3;

[0045] Fig.18 The Janus dressing is applied to the femoral artery bleeding of rats; A is a schematic diagram of femoral artery bleeding in rats; B is the appearance of Control, Bandage, BPHB, CTHB and CLHB applied to the femoral artery bleeding of rats for 30s and 60s, scale = 1cm; C is a statistical diagram of the hemostasis time of each group after femoral artery bleeding in rats, n = 3; D is a statistical diagram of blood loss in each group after femoral artery bleeding in rats, n = 3;

[0046] Fig.19 This is a comparison chart of the hemostasis time between the Janus dressing of the present invention and the Janus dressing of prior research;

[0047] Fig. 20 A diagram showing the functional applications of the Janus patch; A shows the application of BPHB, CTHB and CLHB patches of different shapes on the arm bend and their schematic diagrams, scale bar = 1 cm; B shows the application of BPHB, CTHB and CLHB patches of different shapes on the arm and their schematic diagrams, scale bar = 1 cm; C shows the adhesion of BPHB, CTHB and CLHB patches on the mouse ear and their schematic diagrams, scale bar = 0.5 cm. DETAILED DESCRIPTION

[0048] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.

[0049] The present invention provides a method for preparing a composite hemostatic dressing. Figure 1 As shown, the following steps are included:

[0050] S1. Preparation of cellulose paper

[0051] Cellulose paper is prepared from plant residues. The raw materials are easily available and the prepared cellulose paper is natural and environmentally friendly.

[0052] In some embodiments, the plant residue is selected from at least one of paper mulberry bark, lemongrass and marigold. The plant residue can be any one or more of the above. Cellulose is extracted from the above plant residues to prepare cellulose paper, which has the advantages of being natural and environmentally friendly, high porosity, good mechanical properties and hemostatic properties.

[0053] In some embodiments, the preparation process of cellulose paper includes: removing impurities from plant residues, washing and crushing to obtain fiber raw materials, dispersing the fiber raw materials in water to form a fiber suspension, using the fiber suspension to make cellulose paper, and then drying the cellulose paper. Impurities such as pectin and lignin are removed by removing impurities, and water can be used for multiple washings, and the cellulose paper is crushed to form fine fibers. The fiber suspension can be made into cellulose paper by a papermaking machine, hand-made papermaking, etc., and then the water is removed by drying.

[0054] Furthermore, there is no limitation on the method of removing impurities, and lime water can be used for removing impurities, and the plant residues can be soaked in lime water to effectively remove impurities such as pectin and lignin.

[0055] In some embodiments, the thickness of the prepared cellulose paper can be 100 μm-150 μm (such as 100 μm, 110 μm, 120 μm, 130 μm, 140 μm, 150 μm, etc.), and the mechanical properties and hemostatic properties of the hemostatic material can be guaranteed within this thickness range. The fiber length in the cellulose paper is 10 μm-100 μm, and the fiber diameter is 1 μm-10 μm. The fiber size in the cellulose paper is within the above range and has good flexibility and mechanical strength.

[0056] Specifically, the fiber length in the cellulose paper may be 10 μm, 30 μm, 50 μm, 80 μm, 100 μm, etc., and the fiber diameter may be 1 μm, 3 μm, 5 μm, 8 μm, 10 μm, etc.

[0057] S2. Preparation of polyacrylamide hydrogel

[0058] Polyacrylamide hydrogels were made from SBMA hydrogels and exhibited high porosity, excellent mechanical properties, elasticity, and biocompatibility.

[0059] The preparation process of SBMA hydrogel includes: irradiating polyacrylamide (SBMA) powder with ultraviolet light in the presence of a crosslinking agent and a photoinitiator, obtaining a hydrogel layer after crosslinking and curing, swelling the hydrogel layer to achieve better performance, and taking out the swollen hydrogel layer to obtain the final product.

[0060] In the actual operation process, the process of preparing the hydrogel layer includes: mixing and dissolving polyacrylamide and water to obtain a polyacrylamide solution; mixing the polyacrylamide solution, a crosslinker and a photoinitiator, stirring evenly to obtain a reaction solution; pouring the reaction solution into a mold, and crosslinking and curing by ultraviolet light to obtain a hydrogel layer. Specifically, the crosslinker can be selected from at least one of polyethylene glycol dimethacrylate (PEGDMA) and polyethylene glycol (PEG), and the raw material of the crosslinker can be selected from any one or more of the above; the photoinitiator can be selected from at least one of 2959, DMSO, and a derivative of DMSO, and the raw material of the photoinitiator can be selected from any one or more of the above.

[0061] In some embodiments, the thickness of the prepared polyacrylamide hydrogel is 1 μm-2 μm (such as 1.0 μm, 1.5 μm, 2.0 μm, etc.), and the mechanical properties of the hemostatic material can be guaranteed within this thickness range. The pore size of the polyacrylamide hydrogel is 10 μm-100 μm, such as 10 μm, 30 μm, 50 μm, 80 μm, 100 μm, etc.; the mechanical properties of the polyacrylamide hydrogel meet the following requirements: the tensile strength is greater than 1 MPa, and the elongation at break is greater than 100%. The polyacrylamide hydrogel has good biocompatibility and is non-cytotoxic.

[0062] S3, forming Janus structure

[0063] Cellulose paper is laminated with polyacrylamide hydrogel to form a relatively hydrophobic-hydrophilic Janus structure.

[0064] In some embodiments, the steps for forming the Janus structure are as follows: placing the polyacrylamide hydrogel on a flat surface, attaching cellulose paper to the polyacrylamide hydrogel layer, making the cellulose paper and the hydrogel in close contact, and hydrogen bonding occurs between the hydrophobic groups of the cellulose paper and the hydrophilic groups of the hydrogel to form the Janus structure. The prepared Janus dressing is cut and trimmed to obtain the final product.

[0065] In some embodiments, the laminating temperature is controlled to be 20°C-40°C, such as 20°C, 25°C, 30°C, 35°C, 40°C, etc.; the laminating time is 10min-30min, such as 10min, 15min, 20min, 25min, 30min, etc.

[0066] It should be noted that the preparation method of the composite hemostatic dressing provided in the embodiment of the present invention has the following advantages: (1) the preparation method is simple and easy to operate, and is suitable for large-scale production; (2) the prepared Janus dressing has excellent hemostatic performance, biocompatibility, elasticity and degradability; (3) the material source is wide, and cellulose can be extracted from a variety of plant residues to achieve diversified utilization of resources.

[0067] The embodiment of the present invention provides a composite hemostatic dressing, comprising a cellulose paper layer and a polyacrylamide hydrogel layer bonded to the cellulose paper layer, wherein the cellulose paper layer and the polyacrylamide hydrogel layer form a relatively hydrophobic-hydrophilic Janus structure, which can quickly absorb blood and exudate.

[0068] In some embodiments, the contact angle between the cellulose paper layer and the polyacrylamide hydrogel layer is greater than 90°, and the hydrogen bonding between the cellulose paper layer and the polyacrylamide hydrogel layer is stable.

[0069] It should be noted that the composite hemostatic dressing provided by the embodiment of the present invention has the following advantages: (1) Rapid hemostasis: The Janus structure can quickly absorb blood and exudate, accelerate the coagulation process, and effectively control bleeding. (2) Reduce blood loss: Effectively control bleeding, reduce blood loss, and reduce patient mortality. (3) Natural and environmentally friendly: Cellulose paper is prepared using plant residues to achieve resource recycling and reduce environmental pollution. (4) Good biocompatibility: Both cellulose paper and hydrogel have good biocompatibility, are non-irritating to the skin, and avoid allergic reactions. (5) Good elasticity: SBMA hydrogel has good elasticity, can adapt to the wound morphology, and provide comfort. (6) Anti-adhesion: The Janus structure can reduce the adhesion between the dressing and the wound, facilitate dressing replacement, and relieve patient pain. (7) Degradable: Both cellulose and hydrogel are biodegradable, reducing environmental pollution. (8) Antibacterial: SBMA hydrogel has antibacterial properties, can prevent infection, and reduce the risk of infection. (9) Promote healing: Both cellulose paper and hydrogel can promote cell proliferation and tissue regeneration, and accelerate wound healing.

[0070] The composite hemostatic dressing provided in the embodiment of the present invention has the functions of rapidly absorbing blood and exudate, effectively controlling bleeding, and promoting wound healing, and can be used in the preparation of hemostatic drugs.

[0071] The composite hemostatic dressing can be used for: (1) trauma hemostasis, for various traumatic bleeding, such as surgical incisions, trauma, burns, etc. (2) tooth extraction hemostasis, for hemostasis after tooth extraction. (3) post-vaccination hemostasis, for hemostasis of small wounds after vaccination. (4) Other applications: can be used in other scenarios where hemostasis is required, such as animal surgery, etc.

[0072] It should be noted that the method of using the composite hemostatic dressing provided by the embodiment of the present invention is as follows: (1) clean the wound and place the dressing on the bleeding site; (2) press the dressing firmly to ensure that it fits tightly against the wound; (3) observe the hemostatic effect and replace the dressing if necessary.

[0073] The features and performance of the present invention are further described in detail below in conjunction with the embodiments.

[0074] Example 1

[0075] This embodiment provides a method for preparing a composite hemostatic dressing, comprising the following steps:

[0076] (1) Preparation of cellulose paper

[0077] The bark of the paper mulberry tree is used as the basic raw material. First, it is carefully cleaned and fully dried, and then cut into small pieces for easy handling. Then, these small pieces of paper mulberry bark are put into the crusher, and the crushing parameters are finely adjusted to achieve the desired effect. After the crushing is completed, the particle size of the crushed product is detected using precision equipment such as a sieving instrument or a high-precision laser particle size analyzer to ensure that the particle size of the slag is accurately controlled at about 20μm. For samples that meet the particle size requirements, they are collected and prepared for subsequent processing. The slag is soaked in lime water, and after soaking for 48 hours, it is filtered, and the solid material obtained is washed with water and crushed to obtain a fine fibrous material with a particle size of 5μm. The fine fibrous material and water are mixed to form a fiber suspension, and the solid content is controlled to be 5%. The fiber suspension is made into cellulose paper using a papermaking machine, and the prepared cellulose paper is dried to obtain a cellulose paper with a thickness of 2μm for standby use.

[0078] (2) Preparation of SBMA hydrogel

[0079] SBMA powder (purchased from Sigma-Aldrich, model SBMA) and water were mixed to obtain a 2.50 g / mL SBMA solution. The SBMA solution, crosslinker (PEGDMA) and photoinitiator (2959) were stirred evenly to obtain a reaction solution. The mass ratio of the crosslinker to the SBMA powder was 10:100, and the mass ratio of the photoinitiator to the SBMA powder was 1:1000.

[0080] The reaction solution was poured into the mold and cross-linked and cured by ultraviolet light. The ultraviolet light power was controlled to 40 mW / cm2 , irradiation time is 20 min, curing temperature is 60°C, and curing time is 20 min to obtain a hydrogel layer.

[0081] The hydrogel layer was placed in pure water to swell for 48 h, and then taken out to obtain 2.5 g / mL SBMA hydrogel with a thickness of 1.0 mm.

[0082] (3) Formation of Janus structure

[0083] The hydrogel layer is placed on a flat surface, and cellulose paper is laminated on the hydrogel layer at room temperature (about 20°C, the same below) so that it is in close contact with the hydrogel layer for 20 minutes. Hydrogen bonds will occur between the hydrophobic groups of the cellulose paper layer and the hydrophilic groups of the hydrogel layer to form a Janus structure. The prepared Janus dressing is cut and trimmed to obtain the final product.

[0084] Performance test: Janus dressing was tested for blood absorption, exudate absorption, water vapor permeability, skin irritation, blood compatibility, cell compatibility, etc. Janus dressing was applied to a rat tooth extraction bleeding model to test its hemostatic performance.

[0085] Example 2

[0086] This embodiment provides a method for preparing a composite hemostatic dressing, comprising the following steps:

[0087] (1) Preparation of cellulose paper

[0088] Using lemongrass as raw material, the preparation steps refer to Example 1.

[0089] (2) Preparation of SBMA hydrogel

[0090] A 2.5 g / mL SBMA hydrogel with a thickness of 0.5 mm was prepared. The preparation process was similar to that in Example 1.

[0091] (3) Formation of Janus structure

[0092] Refer to Example 1.

[0093] Performance testing: (1) The Janus dressing was tested for blood absorption, exudate absorption, water vapor permeability, skin irritation, blood compatibility, cell compatibility, etc. (2) The Janus dressing was applied to the rat tail amputation bleeding model to test its hemostatic performance.

[0094] Example 3

[0095] This embodiment provides a method for preparing a composite hemostatic dressing, comprising the following steps:

[0096] (1) Preparation of cellulose paper

[0097] Calendula officinalis was used as raw material, and the preparation steps were referred to Example 1.

[0098] (2) Preparation of SBMA hydrogel

[0099] A 2.5 g / mL SBMA hydrogel with a thickness of 1.5 mm was prepared. The preparation process was similar to that in Example 1.

[0100] (3) Formation of Janus structure

[0101] Refer to Example 1.

[0102] Performance testing: (1) The Janus dressing was tested for blood absorption, exudate absorption, water vapor permeability, skin irritation, blood compatibility, cell compatibility, etc. (2) The Janus dressing was applied to a rat liver bleeding model to test its hemostatic properties.

[0103] Example 4

[0104] This embodiment provides a method for preparing a composite hemostatic dressing, comprising the following steps:

[0105] (1) Preparation of cellulose paper

[0106] Using paper mulberry bark as raw material, the preparation steps refer to Example 1.

[0107] (2) Preparation of SBMA hydrogel

[0108] A 2.5 g / mL SBMA hydrogel with a thickness of 0.5 mm was prepared. The preparation process was similar to that in Example 1.

[0109] (3) Formation of Janus structure

[0110] Refer to Example 1.

[0111] Performance testing: (1) Add silver nanoparticles to Janus dressing to give it antibacterial properties. (2) Test Janus dressing for blood absorption, exudate absorption, water vapor permeability, skin irritation, blood compatibility, cell compatibility, antibacterial properties, and healing performance. (3) Apply Janus dressing to a rat femoral artery bleeding model to test its hemostatic properties.

[0112] Example 5

[0113] This embodiment provides a method for preparing a composite hemostatic dressing, comprising the following steps:

[0114] (1) Preparation of cellulose paper

[0115] Using lemongrass as raw material, the preparation steps refer to Example 1.

[0116] (2) Preparation of SBMA hydrogel

[0117] A 2.5 g / mL SBMA hydrogel with a thickness of 1.0 mm was prepared. The preparation process was similar to that in Example 1.

[0118] (3) Formation of Janus structure

[0119] Refer to Example 1.

[0120] Performance testing: (1) Add calcium ions to Janus dressing to enhance its hemostatic properties. (2) Test Janus dressing for blood absorption, exudate absorption, water vapor permeability, skin irritation, blood compatibility, cell compatibility, antibacterial properties, and healing performance. (3) Apply Janus dressing to mouse ears to test its adhesion properties.

[0121] Example 6

[0122] This embodiment provides a method for preparing a composite hemostatic dressing, comprising the following steps:

[0123] (1) Preparation of cellulose paper

[0124] Calendula officinalis was used as raw material, and the preparation steps were referred to Example 1.

[0125] (2) Preparation of SBMA hydrogel

[0126] A 2.5 g / mL SBMA hydrogel with a thickness of 1.5 mm was prepared. The preparation process was similar to that in Example 1.

[0127] (3) Formation of Janus structure

[0128] Refer to Example 1.

[0129] Performance test: (1) Prepare Janus dressings into shapes such as stars, ducks, rabbits, elephants, whales, etc., and use them to stop bleeding after injections and blood draws. (2) Perform performance tests on the prepared Janus hemostatic patches.

[0130] Example 7

[0131] This embodiment provides a method for preparing a composite hemostatic dressing, comprising the following steps:

[0132] (1) Preparation of cellulose paper

[0133] Using paper mulberry bark as raw material, the preparation steps refer to Example 1.

[0134] (2) Preparation of SBMA hydrogel

[0135] A 2.5 g / mL SBMA hydrogel with a thickness of 0.5 mm was prepared. The preparation process was similar to that in Example 1.

[0136] (3) Formation of Janus structure

[0137] Refer to Example 1.

[0138] Performance test: (1) Prepare Janus dressings into patches of different shapes and use them on arms (blood drawing, vaccination) and mice ears. (2) Perform performance test on the prepared Janus patches.

[0139] Example 8

[0140] This embodiment provides a method for preparing a composite hemostatic dressing, comprising the following steps:

[0141] (1) Preparation of cellulose paper

[0142] Using lemongrass as raw material, the preparation steps refer to Example 1.

[0143] (2) Preparation of SBMA hydrogel

[0144] A 2.5 g / mL SBMA hydrogel with a thickness of 1.0 mm was prepared. The preparation process was similar to that in Example 1.

[0145] (3) Formation of Janus structure

[0146] Refer to Example 1.

[0147] Performance testing: (1) Add growth factors to Janus dressings to promote wound healing. (2) Test Janus dressings for blood absorption, exudate absorption, water vapor permeability, skin irritation, blood compatibility, cell compatibility, antibacterial properties, and healing performance. (3) Apply Janus dressings to a rat burn wound model to test their healing performance.

[0148] Example 9

[0149] This embodiment provides a method for preparing a composite hemostatic dressing, comprising the following steps:

[0150] (1) Preparation of cellulose paper

[0151] Calendula officinalis was used as raw material, and the preparation steps were referred to Example 1.

[0152] (2) Preparation of SBMA hydrogel

[0153] A 2.5 g / mL SBMA hydrogel with a thickness of 1.5 mm was prepared. The preparation process was similar to that in Example 1.

[0154] (3) Formation of Janus structure

[0155] Refer to Example 1.

[0156] Performance test: (1) The Janus dressing was made into a wearable bandage for hemostasis and fixation of limb injuries. (2) The prepared Janus bandage was subjected to performance test.

[0157] Example 10

[0158] This embodiment provides a method for preparing a composite hemostatic dressing, comprising the following steps:

[0159] (1) Preparation of cellulose paper

[0160] Cellulose paper was prepared using paper mulberry bark, lemongrass and marigold as raw materials, respectively, and the preparation steps were referred to Example 1.

[0161] (2) Preparation of SBMA hydrogel

[0162] A 2.5 g / mL SBMA hydrogel with a thickness of 1.0 mm was prepared. The preparation process was similar to that in Example 1.

[0163] (3) Formation of Janus structure

[0164] Refer to Example 1.

[0165] Performance testing: (1) Add nanomaterials to Janus dressings to improve their antibacterial and healing properties. (2) Test Janus dressings for blood absorption, exudate absorption, water vapor permeability, skin irritation, blood compatibility, cell compatibility, antibacterial properties, and healing properties. (3) Apply Janus dressings to a variety of trauma models to test their hemostatic and healing properties.

[0166] Embodiment 11

[0167] The only difference from Example 1 is that steps (2) and (3) are not performed, that is, the SBMA hydrogel layer is not prepared.

[0168] Result analysis:

[0169] Figure 2 This is a physical picture of the surface and cross section of the Janus dressing of Example 1. It can be seen that the surface of the dressing is smooth without obvious defects, and the hydrogel layer and the cellulose paper layer are tightly attached without obvious stratification.

[0170] Figure 3This is a test chart of the blood absorption performance of Janus dressing. In the figure, BP represents BP cellulose paper, CT represents CT cellulose paper, CL represents CL cellulose paper, BP represents BP cellulose paper, and HB represents SBMA hydrogel. Compared with the Control group, # represents P<0.05, ## represents P<0.01, and ### represents P<0.001. Compared with the other two groups except the Control group, * represents P<0.05, ** represents P<0.01, and *** represents P<0.001. It can be seen that the blood absorption rate of the BPHB group is the highest, followed by the CTHB group, and the CLHB group is the lowest, all of which are significantly higher than the Control group, indicating that the Janus dressing has excellent blood absorption performance.

[0171] Figure 4 This is a test chart of the exudate absorption performance of Janus dressing. Compared with the Control group, ### indicates P<0.001. Compared with the other two groups except the Control group, * indicates P<0.05 and *** indicates P<0.001. It can be seen that the exudate absorption rates of the BPHB group, CTHB group and CLHB group are significantly higher than those of the Control group, indicating that Janus dressing has excellent exudate absorption performance.

[0172] Figure 5 This is the water vapor permeability test chart of Janus dressing. It can be seen that the WVTR values ​​of BPHB group, CTHB group and CLHB group are close to 2500g / m2 / 24h, which is in line with the WVTR index of ideal dressing, indicating that Janus dressing has good air permeability.

[0173] Figure 6 This is a radar chart comparing the relevant properties of SBMA hydrogels with three thicknesses. It can be seen that the SBMA hydrogel with a thickness of 1.0 mm performs best in terms of mechanical properties, adhesion properties, absorption properties, etc.

[0174] Figure 7 The figure shows the rapid blood absorption performance of Janus structure, where *** indicates P < 0.001. (F) Relative blood permeability of BP vs BPHB, CT vs CTHB and CL vs CLHB. It can be seen that the blood absorption rate of BPHB group, CTHB group and CLHB group is significantly faster than that of BP, CT and CL groups, indicating that Janus structure has the effect of accelerating liquid absorption.

[0175] Figure 8(F) Relative permeability of BP vs BPHB, CT vs CTHB and CL vs CLHB. It can be seen that the absorption rate of BPHB, CTHB and CLHB groups was significantly faster than that of BP, CT and CL groups, indicating that the Janus structure has the effect of accelerating liquid absorption.

[0176] Fig. 9 The figure is a diagram of the mechanism of rapid liquid absorption of the Janus structure, A is a schematic diagram of the Young's equation of cellulose paper, B is a schematic diagram of the Young's equation on the surface of the hydrogel layer, and C is a force analysis of the droplet from the cellulose paper layer to the hydrogel layer based on the Laplace equation. It can be seen from the analysis that the composite hemostatic dressing prepared in the embodiment of the present invention has good blood and exudate absorption performance, which is mainly attributed to the relative hydrophobic-hydrophilic characteristics of the Janus structure and the excellent performance of the cellulose paper and the SBMA hydrogel.

[0177] Fig.10 This is a skin irritation test diagram of Janus dressing. It can be seen that the dressing is non-irritating to the skin and has good biocompatibility.

[0178] Fig.11 This is a blood compatibility test diagram of Janus dressing. It can be seen that the dressing has good blood compatibility.

[0179] Fig.12 This is a diagram of the cell compatibility experiment of Janus dressing. It can be seen that the dressing has good cell compatibility.

[0180] Fig.13 This is a diagram showing the adhesion of red blood cells and platelets on Janus dressings. It can be seen that a large number of red blood cells and platelets are attached to the surface of the BPHB group, CTHB group, and CLHB group, and the formation of fibrin can be seen.

[0181] Fig.14 This is the anti-adhesion test of Janus dressing in mice. After the mouse liver was naturally bleeding for 10 seconds, BPHB, CTHB and CLHB were attached to the wound. The appearance of Janus dressing before and after 60 seconds was removed. The red dotted circle is the wound. Scale bar = 1cm. It can be seen that after the Janus dressing was removed after 60 seconds, there was no obvious dressing residue on the wound, and the wound surface was intact without adhesion.

[0182] Fig.15This is a test chart of Janus dressing applied to rats for tooth extraction bleeding. Compared with the Control group, # indicates P<0.05, ## indicates P<0.01, and ### indicates P<0.001. It can be seen that the amount of bleeding in the BPHB group, CTHB group, and CLHB group was significantly lower than that in the Control group, and the hemostasis time was shorter.

[0183] Fig.16 This is a graph of bleeding after Janus dressing was applied to rat tail amputation. Compared with the Control group, # indicates P<0.05, ## indicates P<0.01, and ### indicates P<0.001. In addition to the Control group, * indicates P<0.05 when compared with the other two groups. It can be seen that the amount of bleeding in the BPHB group, CTHB group, and CLHB group was significantly lower than that in the Control group, and the hemostasis time was shorter.

[0184] Fig.17 This is a graph of hemorrhage in rat livers after Janus dressing was applied. Compared with the Control group, ### indicates P<0.001. It can be seen that the amount of bleeding in the BPHB group, CTHB group, and CLHB group was significantly lower than that in the Control group, and the hemostasis time was shorter.

[0185] Fig.18 This is a graph of femoral artery bleeding in rats after Janus dressing was applied. Compared with the Control group, ### indicates P<0.001. Compared with the other two groups except the Control group, ** indicates P<0.01 and *** indicates P<0.001. It can be seen that the amount of bleeding in the BPHB group, CTHB group and CLHB group was significantly lower than that in the Control group, and the hemostasis time was shorter.

[0186] Fig.19 The comparison chart of the hemostasis time between the Janus dressing provided in Example 1 of the invention and the Janus dressings of prior studies (including the Gauze group, the PH@Gauze group, the PH@CS-MCF group, and the MSN@U group) shows that the hemostasis time of the Janus dressing prepared in the example of the invention in the rat liver bleeding and femoral artery bleeding models is significantly shorter than that of the Janus dressings of prior studies.

[0187] Fig. 20 This is the functional application diagram of the Janus patch. It can be seen that the Janus patch has a good hemostatic effect, a cute shape, and is easy to use.

[0188] Comparative Example 1

[0189] The difference between this comparative example and Example 1 is only that steps (2) and (3) are not performed, that is, hydrogel is not introduced. The surface characteristics of cellulose paper show a certain hydrophobicity, and its contact angle ranges from 70° to 120°, while the hydrogel layer is completely opposite, with significant hydrophilicity, and the contact angle is maintained between 0° and 30°. The smaller this value is, the more significant the hydrophilicity of the material is. In addition, the surface tension of cellulose paper is in the range of 30mN / m to 70mN / m. Compared with the surface tension range of 50mN / m to 70mN / m of the hydrogel layer, the surface energy difference between the two is significant, which enables the hydrogel layer to more effectively contact and adsorb water in the blood, thereby accelerating the hemostasis process. The porous structure of the hydrogel layer has a fine pore size of 1-1000μm, which not only increases its surface area, but also makes it more hydrophilic in the range of 10-1000m 2 / g range, it can efficiently absorb water and cells in the blood, and also promote the smooth exchange of oxygen and nutrients, creating a more favorable environment for wound healing. In addition, as a representative of zwitterionic materials, SBMA hydrogel can actively exchange ions in the blood, especially Ca 2+ The interaction between the hydrogel layer and the cellulose paper significantly enhances its adsorption efficiency and further promotes the hemostatic effect. In summary, compared with the use of cellulose paper alone, the Janus dressing with an integrated hydrogel layer shows obvious advantages in adsorption speed and efficiency, and the latter can achieve the ideal hemostatic effect more quickly. The fiber structure of cellulose paper is relatively fragile, and its breaking strength fluctuates between 20-200MPa. Its elongation at break is also limited, ranging from 5% to 30%, so it is easy to break when stretched or compressed. On the contrary, SBMA hydrogel exhibits stronger mechanical properties due to its cross-linked polymer network structure. Although its breaking strength is in the range of 0.1-10MPa, its elongation at break can be as high as 1-100%, so it has higher durability and stronger mechanical support. Therefore, in terms of mechanical properties, especially tensile properties, cellulose paper is inferior to SBMA hydrogel. When cellulose paper is subjected to pressure or tension, it is more likely to break, which will undoubtedly weaken its hemostatic effect. The cross-linked network structure in the hydrogel provides it with an elastic support force that is at least 10 times that of cellulose paper. This property enables the hydrogel to easily return to its original shape after being stretched or compressed, showing excellent elastic recovery ability. In contrast, the fiber structure of cellulose paper is relatively fragile and lacks elasticity, and it is easy to deform or even break when subjected to force. Therefore, when fitting the wound, the hydrogel can achieve a tighter fit, effectively improving the hemostatic effect.

[0190] Comparative Example 2

[0191] The difference between this comparative example and Example 1 is only that the SBMA hydrogel in step (2) is replaced by PEG hydrogel. First, with regard to adhesion, it is clearly pointed out that the SBMA hydrogel at a concentration of 2.50 g / mL exhibits excellent adhesion ability, and its adhesion strength can reach or even exceed 1.0 MPa. In contrast, the adhesion of the PEG hydrogel (density of 1.67 g / mL) is significantly weaker, only 0.0016 MPa. The SBMA hydrogel can effectively form hydrogen bonds with the hydroxyl groups on the cellulose paper by virtue of the sulfonic acid groups it contains, thereby significantly enhancing its adhesion. In addition, the unique surface pore size and structural characteristics of the SBMA hydrogel enable it to fit the cellulose paper more closely, further improving the adhesion effect. On the contrary, as a non-ionic polymer, the PEG hydrogel lacks charged groups in its molecular structure, and its thicker network structure and smooth surface make it difficult to form a stable chemical bond or close interface contact with the cellulose paper, which to a certain extent limits the overall effectiveness of the Janus dressing. Secondly, from the perspective of mechanical properties, the cross-linked network structure inside the SBMA hydrogel gives it excellent mechanical support, including excellent tensile and compressive properties. In particular, the higher ionic strength in the SBMA hydrogel strengthens the stability of the cross-linked network, thereby improving the overall mechanical properties. It is worth noting that the high porosity of the SBMA hydrogel (the porosity of zwitterionic hydrogels generally ranges from 10% to 90%) helps to reduce its elastic modulus, thereby giving it higher elasticity, and the elastic modulus ranges from about 0.1MPa to 10MPa. In contrast, the tensile properties of PEG hydrogels are limited, and the tensile strength is mostly in the range of 0.1MPa to 1MPa. It is easy to break and difficult to withstand large stress or deformation, which to some extent weakens the stability and hemostatic efficacy of the Janus dressing. Finally, in terms of biocompatibility, SBMA hydrogel performs well. It is not only a non-toxic material that is harmless to cells and tissues, but also biodegradable, with a degradation rate of between 1% and 20% per day, and will not remain in the body for a long time. In addition, SBMA hydrogel can interact positively with organisms, such as promoting cell proliferation, which is beneficial to wound healing. In contrast, PEG hydrogel has relatively poor biocompatibility, and its slow degradation rate, between 0.1% and 10% per day, may lead to residues in the body, and its low biological activity may induce cytotoxicity and increase the risk of allergic or inflammatory reactions, thereby adversely affecting the wound healing process.

[0192] Comparative Example 3

[0193] The only difference between this comparative example and Example 1 is that cellulose paper is not prepared, and the cellulose paper in step (1) is replaced by medical gauze.

[0194] After testing: the absorption rate is between 100% and 300%, the tensile strength is between 0.5MPa and 2MPa, the coagulation time is between 5min and 10min, and it does not have Ca 2+ Medical gauze is a commonly used dressing with good absorbency and breathability, but it does not have the hemostatic properties and Ca release properties of cellulose paper. 2+ Release capabilities.

[0195] Comparative Example 4

[0196] The only difference between this comparative example and Example 1 is that no cellulose paper is prepared, and the cellulose paper in step (1) is replaced by deacetylated ethyl cellulose (d-CEL).

[0197] After testing: the absorption rate is between 300% and 500%, the tensile strength is between 0.1MPa and 1MPa, and the coagulation time is between 10min and 20min. d-CEL does not have Ca 2+ Release ability. d-CEL is a hydrophilic polymer with good water absorption and retention capabilities, but it does not have the hemostatic properties of cellulose paper.

[0198] Comparative Example 5

[0199] The only difference between this comparative example and Example 1 is that cellulose paper is not prepared, and the cellulose paper in step (1) is replaced by chitosan.

[0200] After testing: the absorption rate is between 100% and 300%, the tensile strength is between 0.5MPa and 2MPa, the coagulation time of chitosan is between 5min and 10min, and the Ca 2+ The release capacity is low. Chitosan is a natural polysaccharide with good hemostatic and antibacterial properties, but it does not have the mechanical properties of cellulose paper.

[0201] Comparative Example 6

[0202] The only difference between this comparative example and Example 1 is that cellulose paper is not prepared, and the cellulose paper in step (1) is replaced by gelatin.

[0203] After testing: the absorption rate is between 100% and 300%, the tensile strength is between 0.1MPa and 1MPa, the coagulation time is between 10min and 20min, and the Ca 2+ The release capacity is low. Gelatin is an animal glue that has good adhesion and biocompatibility, but may not have the hemostatic properties and Ca2+ of cellulose paper. 2+ Release capabilities.

[0204] Comparative Example 7

[0205] The only difference between this comparative example and Example 1 is that cellulose paper is not prepared, and the cellulose paper in step (1) is replaced by nanocellulose.

[0206] After testing: the absorption rate may be above 500%, the tensile strength is above 1MPa, the coagulation time is between 5min and 10min, and the Ca 2+ High release capacity. Nanocellulose has a high specific surface area and excellent mechanical properties, but may require special preparation methods and is costly.

[0207] Comparative Example 8

[0208] The difference between this comparative example and Example 1 is that the paper mulberry paper (BP) in step (1) is replaced by citronella paper (CT) and marigold paper (CL).

[0209] After testing: (1) Fiber structure: BP fibers are slender and tightly entangled, CT fibers are thick and thin, and CL fibers are the thickest. (2) Mechanical properties: Maximum weight BP (200g before paper breaks) > CT (100g before paper breaks) > CL (50g before paper breaks); tensile strength BP > CT > CL. (3) Water absorption: absorption rate BP (300%-400%) > CT (450%-500%) > CL (300%-350%). (4) Ca 2+ Release: The release amount is the same in the first 2 hours, and after 2 hours, the release amount of CL is greater than that of BP and CT. (5) Coagulation function: The blood coagulation index (BCI) of BP, CT, and CL is ≈10%; coagulation time BP (4min) <CT(5.33±0.47min)<CL(5min)。

[0210] It can be seen that using paper mulberry paper (BP) as a substrate can further improve the mechanical properties and coagulation function.

[0211] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A composite hemostatic dressing, characterized in that: The invention comprises a cellulose paper layer and a polyacrylamide hydrogel layer bonded to the cellulose paper layer.

2. The composite hemostatic dressing according to claim 1, characterized in that: The cellulose paper layer and the polyacrylamide hydrogel layer form a Janus structure; and / or, the contact angle between the cellulose paper layer and the polyacrylamide hydrogel layer is greater than 90°; And / or, the thickness of the cellulose paper layer is 100 μm-150 μm, and the thickness of the polyacrylamide hydrogel layer is 1 μm-2 μm.

3. The composite hemostatic dressing according to claim 1 or 2, characterized in that: The pore size of the polyacrylamide hydrogel layer is 10 μm-100 μm; And / or, the tensile strength of the polyacrylamide hydrogel layer is greater than 1 MPa, and the elongation at break is greater than 100%.

4. The composite hemostatic dressing according to claim 1 or 2, characterized in that: The fiber length in the cellulose paper layer is 10 μm-100 μm, and the fiber diameter is 1 μm-10 μm.

5. A method for preparing the composite hemostatic dressing according to any one of claims 1 to 4, characterized in that: include: The cellulose paper and the polyacrylamide hydrogel were laminated together.

6. The preparation method according to claim 5, characterized in that: placing the polyacrylamide hydrogel on a flat surface and attaching the cellulose paper to the polyacrylamide hydrogel; The laminating temperature is controlled at 20℃-40℃ and the laminating time is 10min-30min.

7. The preparation method according to claim 5, characterized in that: The cellulose paper is prepared from plant residues; Wherein, the plant residue is selected from at least one of paper mulberry bark, lemongrass and marigold.

8. The preparation method according to claim 7, characterized in that: The preparation process of the cellulose paper comprises: removing impurities from the plant residues, washing them, and crushing them to obtain fiber raw materials; Dispersing the fiber raw material in water to form a fiber suspension, and using the fiber suspension to make cellulose paper; drying the cellulose paper; Preferably, the impurity removal process comprises: soaking the plant residues in lime water.

9. The preparation method according to claim 5, characterized in that: The preparation process of the polyacrylamide hydrogel comprises: irradiating polyacrylamide with ultraviolet light in the presence of a crosslinking agent and a photoinitiator, obtaining a hydrogel layer after crosslinking and curing, and performing swelling treatment on the hydrogel layer; Preferably, the process of preparing the hydrogel layer includes: mixing and dissolving polyacrylamide and water to obtain a polyacrylamide solution, mixing the polyacrylamide solution, the cross-linking agent and the photoinitiator to obtain a reaction solution, pouring the reaction solution into a mold, and cross-linking and curing by ultraviolet light to obtain the hydrogel layer.

10. Use of the composite hemostatic dressing according to any one of claims 1 to 4 or the composite hemostatic dressing prepared by the preparation method according to any one of claims 5 to 9 in the preparation of hemostatic drugs.